Econ Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.98M Sell
104,628
-81,013
-44% -$2.15M 1.25% 33
2026
Q2
$4.47M Buy
185,641
+37,881
+26% +$991K 2.09% 13
2026
Q1
$4.15M Buy
147,760
+122,170
+477% +$3.25M 1.93% 19
2025
Q4
$637K Buy
+25,590
New +$645K 0.32% 65
2022
Q2
– Sell
-493
Closed -$26K – 132
2022
Q1
$26K Sell
493
-40
-8% -$2.08K 0.02% 81
2021
Q4
$31K Buy
+533
New +$26.4K 0.02% 102

Other funds holding PFE

Econ Financial Services's PFE Position: Q3 2026 in Review

Econ Financial Services reduced its Pfizer (PFE) stake by 44% in Q3 2026, selling an estimated $2.15M and leaving 104,628 shares worth $2.98M. The position accounts for 1.25% of the portfolio, ranked #33.

Econ Financial Services first reported a position in PFE in Q4 2021 and has held it in 6 quarters since. The position peaked at $4.47M in Q2 2026. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Econ Financial Services held 104,628 shares of Pfizer worth $2.98M as of Q3 2026.
  • Econ Financial Services sold 81,013 Pfizer shares in Q3 2026, an estimated $2.15M.
  • Pfizer made up 1.25% of Econ Financial Services's portfolio in Q3 2026, its #33 holding.
  • Econ Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 6 quarters since.
  • Econ Financial Services's Pfizer position peaked at $4.47M in Q2 2026.
  • 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Econ Financial Services's 13F filing for Q3 2026, filed 19 Oct 2026.